This inventor holds 1 USPTO granted patent. Top assignee: Soochow University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yanhua Zhai: Innovator in Nanoparticle Drug Delivery
Introduction
Yanhua Zhai is a prominent inventor based in Suzhou, China. She has made significant contributions to the field of drug delivery systems, particularly through her innovative work on nanoparticles. Her research focuses on enhancing the efficacy of cancer treatments by utilizing advanced materials.
Latest Patents
Yanhua Zhai holds a patent for a "Platinum-based drug-/photosensitizer-loaded protein nanoparticle, and preparation method therefor and application thereof." This invention involves a platinum-based drug/photosensitizer complex encapsulated within a protein nanoparticle. The resulting nanoparticles exhibit a small particle size, uniform dispersion, and round shape. They demonstrate excellent chemical and light stability, along with a high capability for generating active oxygen when exposed to near-infrared light. In both cell and animal experiments, these nanoparticles have shown strong cytotoxicity against tumor cells and effective targeting of tumors in vivo. This innovative approach combines chemotherapy and photodynamic therapy, reducing toxic side effects and inhibiting tumor metastasis.
Career Highlights
Yanhua Zhai is affiliated with Soochow University, where she continues her research and development in nanoparticle technology. Her work has garnered attention for its potential to revolutionize cancer treatment methodologies.
Collaborations
Yanhua collaborates with notable colleagues, including Hong Yang and Tao Xu, who contribute to her research endeavors. Their combined expertise enhances the impact of their work in the field of nanomedicine.
Conclusion
Yanhua Zhai's innovative contributions to nanoparticle drug delivery systems represent a significant advancement in cancer treatment. Her patented technology holds promise for improving therapeutic outcomes and minimizing side effects for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile